OncoSec Medical Inc (ONCSQ)

[twiz0019]

You make some good points Sal. As far as other milestones not being able to move the price, I disagree. If they report positive MCC results, they have the possibility of gaining orphan drug status which will move the price. Also, announcing a trial on a new indication I feel will also move the price.

I would just add that I am happy they are "changing" from a monotherapy to a combination. I believe the anti PD1 therapy is the way of the future and their ability to hopefully turn non-responders into responders is game changing! Pierce is here for that reason....he sees this combination trial as huge and if he's on board, so am I.